Last reviewed · How we verify
Ascorbic Acid 1000 MG
At a glance
| Generic name | Ascorbic Acid 1000 MG |
|---|---|
| Also known as | Vitamin C |
| Sponsor | American University of Beirut Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Vitamin C With Steroids for Gastrointestinal GVHD (EARLY_PHASE1)
- The Effect of Vitamin C Supplementation on Gut Microbiota Composition and Function in Healthy Adults (NA)
- Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery (EARLY_PHASE1)
- Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock. (PHASE2)
- Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries (PHASE2)
- Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity (NA)
- Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy (NA)
- Micronutrient Dose Response Study in Bangladesh (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ascorbic Acid 1000 MG CI brief — competitive landscape report
- Ascorbic Acid 1000 MG updates RSS · CI watch RSS
- American University of Beirut Medical Center portfolio CI